FOXO1 and osteoporosis: The disruption of FOXO1 expression or its activity is known to contribute to numerous age-related diseases, such as OA (Sun et al., 2022b; Wang et al., 2020), osteoporosis (Rached et al., 2010) and muscle atrophy (Oyabu et al., 2022).